Table 3.
Marker | Benign vs malignant urothelium | Mean H-score | TMA spot histology | Mean H-score | UrCa Histology | Mean H-score | pT | Mean H-score | TNM stage group | Mean H-score |
---|---|---|---|---|---|---|---|---|---|---|
Pten* | Benign | 100 | Non-invasive | 148 | Pure UrCa | 74 | pT0 | 195 | 0a/0is | 195 |
pT1 | 73 | I | 61 | |||||||
Malignant (p=0.0000) |
42 | Invasive (p=0.0004) |
61 | Aggressive histology (p=0.009) |
34 | pT2 | 79 | II | 80 | |
pT3/4 | 47 | III/IV | 52 | |||||||
phos Akt | Benign | 17 | Non-invasive | 12 | Pure UrCa | 7 | pT0 | 23 | 0a/0is | 23 |
pT1 | 7 | I | 8 | |||||||
Malignant (p=0.0000) |
7 | Invasive (p=0.03) |
6 | Aggressive histology (p=0.04) |
3 | pT2 | 6 | II | 7 | |
pT3/4 | 6 | III/IV | 5 | |||||||
phos S6 | Benign | 117 | Non-invasive | 43 | Pure UrCa | 28 | pT0 | 25 | 0a/0is | 25 |
pT1 | 84 | I | 75 | |||||||
Malignant (p=0.0000) |
27 | Invasive (p=0.1) |
25 | Aggressive histology (p=NS) |
10 | pT2 | 19 | II | 22 | |
pT3/4 | 19 | III/IV | 21 | |||||||
4E-BP1 | Benign | 9 | Non-invasive | 8 | Pure UrCa | 65 | pT0 | 10 | 0a/0is | 10 |
pT1 | 39 | I | 42 | |||||||
Malignant (p=0.0000) |
32 | Invasive (p=0.0055) |
37 | Aggressive histology (p=0.004) |
29 | pT2 | 25 | II | 27 | |
pT3/4 | 37 | III/IV | 33 | |||||||
c-Myc | Benign | 36 | Non-invasive | 24 | Pure UrCa | 2 | pT0 | 5 | 0a/0is | 5 |
pT1 | 14 | I | 14 | |||||||
Malignant (p=0.0000) |
7 | Invasive (p= 0.002) |
5 | Aggressive histology (p=NS) |
8 | pT2 | 7 | II | 9 | |
pT3/4 | 6 | III/IV | 6 | |||||||
p27 | Benign | 69 | Non-invasive | 76 | Pure UrCa | 53 | pT0 | 63 | 0a/0is | 63 |
pT1 | 93 | I | 97 | |||||||
Malignant (p=0.0029) |
51 | Invasive (p= NS) |
47 | Aggressive histology (p=0.04) |
24 | pT2 | 58 | II | 65 | |
pT3/4 | 36 | III/IV | 36 |